Intuitive Surgical Stock Dips on Solid Quarter, but Bulls See Long-Term Value
Intuitive Surgical stock fell sharply after Barron’s coverage of its second-quarter beat, but RBC Capital Markets’ Shagun Singh reiterated an Outperform rating, saying the slowdown in U.S. procedure growth is temporary, not structural. Barron’s notes looming competition from Johnson & Johnson’s Ottova surgical robot and argues the market leader’s long‑term demand remains intact, suggesting the stock could still offer upside despite the day’s weakness.